{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:31:36Z","timestamp":1788003096143,"version":"build-2784847793"},"reference-count":32,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,11]]},"abstract":"<jats:p>The World Health Organization's (WHO) recommendation is 28-day course of meglumine antimoniate (Glucantime<jats:sup>\u00ae<\/jats:sup>, Sanofi Aventis, France) for the treatment of visceral leishmaniasis (VL). The aim of this study was to evaluate the effectiveness of a shorter duration of treatment in regions with low level of resistance to Glucantime. During 13 years, this study was conducted in three phases on 392 patients. In the pilot first phase, we performed splenic punctures in seven patients to assess the correlation between the changes in the parasite load during treatment with Glucantime and defervescence. With defervescence, parasite density was dramatically dropped (<jats:italic>P<\/jats:italic> = 0.014), propounding defervescence as a marker of parasitological response. On the basis of the results, we conducted a randomized trial on 75 patients, comparing the efficacy of continuation of Glucantime therapy for 1, 2, or 3 weeks after defervescence. The treatment course of 1 week after defervescence (mean = 11.7 days) was non-inferior to that of 3 weeks (final cure rate, 96% versus 100%; <jats:italic>P<\/jats:italic> = 0.023). The third phase was a retrospective cohort study of 302 patients treated either with the WHO's regimen or for 7 days after defervescence (intervention group). Relapse was detected in 8.3% patients of the intervention group and in 5% patients following the WHO's regimen (<jats:italic>P<\/jats:italic> = 0.006 for non-inferiority). The final duration of treatment in intervention group was significantly shorter than standard course (13.3 \u00b1 2.6 versus 28 days; <jats:italic>P<\/jats:italic> &lt; 0.001). In summary, treatment of VL with Glucantime for 1 week after defervescence was non-inferior to and appears to be an acceptable alternative to the standard 28-day course for patients in Iran who show a response to antimonial therapy.<\/jats:p>","DOI":"10.4269\/ajtmh.16-0345","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T03:00:16Z","timestamp":1479870016000},"page":"182-189","source":"Crossref","is-referenced-by-count":13,"title":["Effectiveness of Short-Course Meglumine Antimoniate (Glucantime\u00ae) for Treatment of Visceral Leishmaniasis: A 13-Year, Multistage, Non-Inferiority Study in Iran"],"prefix":"10.4269","volume":"96","author":[{"given":"Abdolvahab","family":"Alborzi","sequence":"first","affiliation":[{"name":"Professor Alborzi Clinical Microbiology Research Center, Department of Paediatrics, Nemazee Teaching Hospital, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Pouladfar","sequence":"additional","affiliation":[{"name":"Professor Alborzi Clinical Microbiology Research Center, Department of Paediatrics, Nemazee Teaching Hospital, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Attar","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, TAHA Clinical Trial Group, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."},{"name":"Molecular Pathology Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."},{"name":"Student Research Committee, Cell and Molecular Medicine Research Club, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Falahi","sequence":"additional","affiliation":[{"name":"Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Jafarpour","sequence":"additional","affiliation":[{"name":"Professor Alborzi Clinical Microbiology Research Center, Department of Paediatrics, Nemazee Teaching Hospital, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdollah","family":"Karimi","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Rahim","family":"Kadivar","sequence":"additional","affiliation":[{"name":"Professor Alborzi Clinical Microbiology Research Center, Department of Paediatrics, Nemazee Teaching Hospital, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"ref1","series-title":"Lancet","first-page":"1561","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005"},{"key":"ref2","series-title":"Iran J Clinic Infect Dis","first-page":"99","article-title":"Visceral leishmaniasis; literature review and Iranian experience","volume":"2","author":"Alborzi","year":"2007"},{"key":"ref3","series-title":"Am J Trop Med Hyg","first-page":"306","article-title":"Leishmania tropica-isolated patient with visceral leishmaniasis in southern Iran","volume":"74","author":"Alborzi","year":"2006"},{"key":"ref4","series-title":"N Engl J Med","first-page":"1383","article-title":"Visceral infection caused by Leishmania tropica in veterans of operation desert storm","volume":"328","author":"Magill","year":"1993"},{"key":"ref5","series-title":"Parasitol Res","first-page":"1431","article-title":"Leishmania major infection in a patient with visceral leishmaniasis: treatment with Amphotericin B","volume":"101","author":"Karamian","year":"2007"},{"key":"ref6","series-title":"J Infect Dev Ctries","first-page":"413","article-title":"First molecular-based detection of mucocutaneous leishmaniasis caused by Leishmania major in Iran","volume":"7","author":"Alborzi","year":"2013"},{"key":"ref7","series-title":"PLoS Negl Trop Dis","first-page":"e0003500","article-title":"Species-specific antimonial sensitivity in Leishmania is driven by post-transcriptional regulation of AQP1","volume":"9","author":"Mandal","year":"2015"},{"key":"ref8","series-title":"Am J Trop Med Hyg","first-page":"471","article-title":"Amphotericin B formulations and other drugs for visceral leishmaniasis","volume":"92","author":"Berman","year":"2015"},{"key":"ref9","series-title":"Clin Infect Dis","first-page":"1104","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000"},{"key":"ref10","series-title":"Report of the Informal Meeting on the Chemotherapy of Visceral Leishmaniasis","author":"WHO","year":"1982"},{"key":"ref11","series-title":"J Infect Dis","first-page":"148","article-title":"A comparison of 3 dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya","volume":"148","author":"Chulav","year":"1983"},{"key":"ref12","series-title":"Lancet","first-page":"563","article-title":"Rapid accurate field diagnosis of Indian visceral leishmaniasis","volume":"351","author":"Sundar","year":"1998"},{"key":"ref13","series-title":"East Mediterr Health J","first-page":"294","article-title":"Evaluation of rK39 strip test for the diagnosis of visceral leishmaniasis in infants","volume":"12","author":"Alborzi","year":"2006"},{"key":"ref14","series-title":"East Mediterr Health J","first-page":"879","article-title":"Childhood visceral leishmaniasis complicated by bacterial infections","volume":"6","author":"Kadivar","year":"2000"},{"key":"ref15","series-title":"Ann Trop Med Parasitol","first-page":"14","article-title":"Observation on the use of sodium antimony gluconte (sodium stibogluconate) in treatment of kala-azar","volume":"41","author":"Kirk","year":"1947"},{"key":"ref16","series-title":"Trans R Trop Med Hyg","first-page":"531","article-title":"A review of kala-azar in China from 1949\u20131959","volume":"76","author":"Leng","year":"1982"},{"key":"ref17","series-title":"Curr Opin Infect Dis","first-page":"426","article-title":"Leishmaniasis: treatment updates and clinical practice guidelines review","volume":"28","author":"Copeland","year":"2015"},{"key":"ref18","series-title":"Trends Parasitol","first-page":"502","article-title":"Leishmaniasis current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003"},{"key":"ref19","series-title":"East Afr Med J","first-page":"551","article-title":"A ten year study of kala-azar in Tharke (Meru District Kenya) relapses","volume":"48","author":"Wigers","year":"1971"},{"key":"ref20","series-title":"PLoS Negl Trop Dis","first-page":"e0004118","article-title":"Effectiveness study of paromomycin IM injection (PMIM) for the treatment of visceral leishmaniasis (VL) in Bangladesh","volume":"9","author":"Jamil","year":"2015"},{"key":"ref21","series-title":"PLoS Negl Trop Dis","first-page":"e3169","article-title":"Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study","volume":"8","author":"Sundar","year":"2014"},{"key":"ref22","series-title":"Lancet Glob Health","first-page":"e51","article-title":"Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study","volume":"2","author":"Mondal","year":"2014"},{"key":"ref23","series-title":"J Trop Med","first-page":"676817","article-title":"Introducing single dose liposomal amphotericin B for the treatment of visceral leishmaniasis in rural bangladesh: feasibility and acceptance to patients and health staff","volume":"2014","author":"Maintz","year":"2014"},{"key":"ref24","series-title":"PLoS Negl Trop Dis","first-page":"e0003699","article-title":"Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh","volume":"9","author":"Lucero","year":"2015"},{"key":"ref25","series-title":"PLoS Negl Trop Dis","first-page":"e2613","article-title":"Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial","volume":"8","author":"Khalil","year":"2014"},{"key":"ref26","series-title":"Am J Trop Med Hyg","first-page":"868","article-title":"Quantification of Leishmania infantum kinetoplast DNA for monitoring the response to meglumine antimoniate therapy in visceral leishmaniasis","volume":"88","author":"Pourabbas","year":"2013"},{"key":"ref27","series-title":"East Afr Med J","first-page":"453","article-title":"Is one year follow up justified in kala-azar post-treatment?","volume":"71","author":"Nyakundi","year":"1994"},{"key":"ref28","series-title":"Indian J Med Res","first-page":"245","article-title":"Immune responses in kala-azar","volume":"123","author":"Saha","year":"2006"},{"key":"ref29","series-title":"J Clin Microbiol","first-page":"3905","article-title":"A correlative study of splenic parasite score and peripheral blood parasite load estimation by qPCR in visceral leishmaniasis","volume":"53","author":"Sudarshan","year":"2015"},{"key":"ref30","series-title":"Indian J Med Res","first-page":"563","article-title":"Clinical profile of cases of kala-azar in Bihar","volume":"70","author":"Aikat","year":"1979"},{"key":"ref31","series-title":"Clin Infect Dis","first-page":"1104","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000"},{"key":"ref32","series-title":"PLoS Negl Trop Dis","first-page":"e3374","article-title":"Prognostic factors and scoring system for death from visceral leishmaniasis: an historical cohort study in Brazil","volume":"8","author":"Coura-Vital","year":"2014"}],"container-title":["The American Society of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/96\/1\/article-p182.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/96\/1\/article-p182.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/96\/1\/article-p182.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T22:44:48Z","timestamp":1723070688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/96\/1\/article-p182.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":32,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.16-0345","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]}}}